# Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

> **NCT07412132** · PHASE3 · RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 40 (estimated)

## Conditions studied

- Bipolar Affective Disorder

## Interventions

- **DRUG:** Lacosamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07412132
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-09
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412132, "Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07412132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*